Gilead Sciences excluded Latin America and the Caribbean from affordable drug access, prompting denouncement from AHF.
1 report, 1 independent
Updated Jul 10
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Gilead Sciences excluded Latin America and the Caribbean from affordable drug access, prompting denouncement from AHF.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
-
Gilead Sciences
American company
- Required regulatory filings regarding institutional holdings were made by Gilead Sciences, Inc. with the Securities and Exchange Commission on June 11, 2026.
- A pilot program is underway involving the federal government, Benue State, and Gilead Sciences, with the state participating in the drug supply management.
-
AIDS Healthcare Foundation
nonprofit organization in Durban, South Africa
Nothing else this week.
Related events
Coverage
Newest first; wire copies grouped- Business WireAHF: Gilead’s Greed Costs Latin America HIV Protection MEXICO CITY, July 09, 2025--(BUSINESS WIRE)--AIDS Healthcare Foundation (AHF) denounces Gilead Sciences for once again excluding Latin America a